Latest Trials

Systemic therapy trial

An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With...

This phase II trial is evaluating Obinutuzumab alone and in combination with a new oral drug (BGB-3111) for the treatment of non-Hodgkin follicular lymphoma that has gotten worse or not responded to prior treatment

Status : Recruiting

Systemic therapy trial

1stFLOR : First-line Treatment for Grade 1-3A Follicular Lymphoma Using Opdivo (Nivolumab) Plus...

This phase I trial is trying to determine whether it is safe to give the drug Nivolumab before and in combination with the drug Rituximab, in patients who have previously untreated

Status : Recruiting

Systemic therapy trial

AvR-CHOP : Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With...

This phase I trial is assessing induction and maintenance therapy (with Avelumab and R-CHOP chemotherapy) in patients with Diffuse Large B Cell Lymphoma (DLBCL)

Status : Recruiting

Systemic therapy trial

A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus...

This phase III trial is trying to determine whether REGN2810 (a type of drug known as a monoclonal antibody) is better than standard chemotherapy as a first line treatment for people with advanced non-small cell lung cancer (PD L1+)

Status : Recruiting

Systemic therapy trial

IMpassion031 : A Phase III Randomized Study to Investigate the Efficacy and Safety of Atezolizumab...

This phase III trial is combining a drug (Atezolizumab) that is commonly used in immunotherapy, with a type of chemotherapy treatment, in patients with primary invaisive triple negative breast cancer

Status : Recruiting

Systemic therapy trial

LOXO-RET-17001 : A Phase 1 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors, Including...

This phase I trial is evaluating a new oral drug (LOXO-292) in patients with Non-Small Cell (NSC) Lung Cancer, Medullary Thyroid Cancer (MTC) or another type of cancer with increased RET activity

Status : Recruiting

Systemic therapy trial

An International, Phase 3, Open-Label, Randomized Study of BGB-3111 Compared With...

This phase III trial is comparing an oral drug (BGB-3111) with a combined treatment of Bendamustine and Rituximab, in patients with previously untreated Chronic Lymphocytic Leukaemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Status : Recruiting

Systemic therapy trial

A Phase 1, Multicenter, Open-label, Multiple Dose-escalation Study of ARX788,...

This phase I trial is evaluating a new intravenous drug (ARX788) in patients with HER2+ advanced cancers

Status : Recruiting

Systemic therapy trial

M16-106 : A Phase 1 Dose Escalation, Open-Label Study of Venetoclax in Combination With Navitoclax...

This phase I trial is combining two oral drugs (Venetoclax and Navitoclax) with chemotherapy in patients with Acute Lymphoblastic Leukaemia (ALL) or Lymphoblastic Lymphoma that has gotten worse or not responded to treatment

Status : Recruiting

Systemic therapy trial

IPATunity130 : A Double-Blind, Placebo-Controlled, Randomized Phase III Study of Ipatasertib in...

This phase II/III trial is evaluating an oral drug (Ipatasertib) alone and in combination with a chemotherapy drug, for the treatment of advanced triple negative breast cancer or hormone receptor-positive, HER-2 negative breast cancer

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.